Clinical trials: Thyroid Eye Disease, TED
Thyroid Eye Disease
Evaluation of K9 in Subjects With Thyroid Eye Disease (TED)
The study is comprised of two cohorts. Cohort 1 will examine pharmacokinetics of K9 in 3 healthy volunteers over 24 hours. This cohort has been completed. Cohort 2 will involve up to 10 patients with TED.
- Trial name
- NCT06467435
- Testing
- Kamuvudine-9
- Where
- United States
- Volunteers
- 4 people
- Sponsor
- Peter Timoney